Lynx Revenues Down, Net Loss Up

genomeweb
360dx

Lynx Revenues Down, Net Loss Up

Feb 26, 2003

NEW YORK, Feb. 26 -- Lynx Therapeutics recorded a net loss of $3 million for the fourth quarter ending Dec. 31, the company reported today.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Guardant Health Q3 Revenues Jump 95 Percent
Agilent Q4 Revenues Up 9 Percent
Invivoscribe Submits FLT3 Mutation Assay CDx to Japanese Regulators
African Pan-Genome Analysis Reveals Significant Non-Reference Genome Sequences
Myriad Genetics to Repurchase $50M in Shares From Bank of America
NSGC: Genetic Counseling Can Ease Fear, Increase Empowerment Among Heart Disease Patients

The Scan

Free-Ish

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.

This Week in PLOS

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

Isolation Worries

An opinion piece at Bloomberg discusses China's stance on genomic research.

Shaken Identity

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Main menu